Mangalam Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE584F01014
  • NSEID: MANGALAM
  • BSEID: 532637
INR
29.90
0.9 (3.1%)
BSENSE

Apr 02

BSE+NSE Vol: 40.17 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 138636,
    "name": "Mangalam Drugs",
    "stock_name": "Mangalam Drugs",
    "full_name": "Mangalam Drugs and Organics Ltd",
    "name_url": "stocks-analysis/mangalam-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "29.90",
    "chg": 0.9,
    "chgp": "3.1%",
    "dir": 1,
    "prev_price": "29.00",
    "mcapval": "44.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532637,
    "symbol": "MANGALAM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE584F01014",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "40.17 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/mangalam-drugs-138636-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "138636",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/mangalam-drugs-and-organics-138636"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "26-Mar-2026",
      "details": "Outcome of Board meeting to accept the resignation tendered by Ms. Anuradha Pandey as Company Secretary & Compliance Officer(KMP) & Appointment of Ms. Shweta Patel as Company Secretary & Compliance Officer (KMP) of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting For Resignation Tendered By CS Anuradha Pandey Accepted By The Board Approval For The Appointment Of New Company Secretary Nominated By NRC Ms. Shweta Patel.",
      "datetime": "26-Mar-2026",
      "details": "Resignation tendered by CS Anuradha Pandey accepted by the Board approval for the appointment of New Company Secretary nominated by NRC Ms. Shweta Patel.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Board Meeting Intimation To Be Held On 26Th March 2026",
      "datetime": "24-Mar-2026",
      "details": "Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/03/2026 inter alia to consider and approve Board Meeting intimation to be held on 26th March 2026 for taking note of Resignation of Ms. Anuradha Pandey as Company Secretary & Compliance Officer of the Company w.e.f. 29th March 2026 and approval of appointment of Ms. Shweta Patel as Company Secretary & Compliance Officer of the Company w.e.f. 1st April 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mangalam Drugs and Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 21 Dec 17",
          "dt": "2017-12-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Change in Management

26-Mar-2026 | Source : BSE

Outcome of Board meeting to accept the resignation tendered by Ms. Anuradha Pandey as Company Secretary & Compliance Officer(KMP) & Appointment of Ms. Shweta Patel as Company Secretary & Compliance Officer (KMP) of the Company.

Board Meeting Outcome for Outcome Of Board Meeting For Resignation Tendered By CS Anuradha Pandey Accepted By The Board Approval For The Appointment Of New Company Secretary Nominated By NRC Ms. Shweta Patel.

26-Mar-2026 | Source : BSE

Resignation tendered by CS Anuradha Pandey accepted by the Board approval for the appointment of New Company Secretary nominated by NRC Ms. Shweta Patel.

Board Meeting Intimation for Board Meeting Intimation To Be Held On 26Th March 2026

24-Mar-2026 | Source : BSE

Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/03/2026 inter alia to consider and approve Board Meeting intimation to be held on 26th March 2026 for taking note of Resignation of Ms. Anuradha Pandey as Company Secretary & Compliance Officer of the Company w.e.f. 29th March 2026 and approval of appointment of Ms. Shweta Patel as Company Secretary & Compliance Officer of the Company w.e.f. 1st April 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Mangalam Drugs and Organics Ltd has declared 5% dividend, ex-date: 21 Dec 17

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available